Pfizer expects 2023 sales to decline by as much as 33% compared with record-breaking 2022

The pharmaceutical company booked $100.3 billion for full-year 2022, an all-time high.

from Health and Science https://ift.tt/oJFfSLA
https://ift.tt/IZsVCRL
https://ift.tt/Cv4szEa